Concourse Financial Group Securities, Inc. Biolife Solutions Inc Transaction History
Concourse Financial Group Securities, Inc.
- $1.64 Billion
- Q3 2024
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding BLFS
# of Institutions
198Shares Held
44.9MCall Options Held
8.2KPut Options Held
4K-
Casdin Capital, LLC New York, NY8.71MShares$231 Million16.93% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$145 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA3.2MShares$84.9 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.85MShares$75.5 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY1.58MShares$41.8 Million0.2% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $1.13B
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...